» Articles » PMID: 38995530

Airways Relaxant and Antiasthmatic Activity of Aconitum Heterophyllum Wall Ex Royle. Roots: A Mechanistic Insight

Overview
Date 2024 Jul 12
PMID 38995530
Authors
Affiliations
Soon will be listed here.
Abstract

Aconitum heterophyllum Wall ex Royle. (Ranunculaceae) is a traditional medicinal herb that has shown extensive pharmacological potential to treat cough, diarrhea, and infectious diseases but no scientific evidence is available to validate its antiasthmatic potential. In this study, we have investigated the tracheal relaxation and antiasthmatic activity of the selected bioactive fraction of A. heterophyllum. Chemical profiling of the most effective fraction obtained via bioassay-guided fractionation was done using LC-MS (Liquid chromatography-mass spectrometry, a technique utilized in the identification, separation, and quantification of known and unknown compounds). Molecular docking analysis of characterized constituents was performed to recognize the binding receptors, followed by an evaluation of the tracheal relaxation ability of active fraction. An acute oral toxicity study of the most effective fraction was done using OECD guidelines 423. Further, the therapeutic efficacy of the fraction was validated in asthma using a guinea pig model of ovalbumin (OVA) induced allergic asthma. The bio-guided activity revealed that hydro-methanolic extract of A. heterophyllum roots (F-1) was the most active fraction. LC-MS analysis of F-1 showed the presence of six major bioactive compounds in F-1. Molecular docking studies revealed strong binding affinities of identified constituents with histaminic receptor (H) and muscarinic receptor (M). The ex vivo study demonstrated smooth muscle relaxant activity of F-1 via dysregulating diverse signal transduction pathways viz. histaminic and muscarinic receptors antagonism (non-competitive), stimulation of β-adrenergic receptor pathway, and soluble guanylyl cyclase activation. The findings of acute oral toxicity studies revealed that F-1 had no toxicity up to the dose of 2000 mg/Kg. The anti-asthmatic therapeutic efficacy of F-1 was further confirmed by the amelioration of respiratory hyperresponsiveness in asthmatic guinea pigs. This is the first evidence-based study showing the antiasthmatic therapeutic potential of the traditionally used herb A. heterophyllum through, computational and animal studies.

References
1.
Balkrishna A, Solleti S, Singh H, Tomer M, Sharma N, Varshney A . Calcio-herbal formulation, Divya-Swasari-Ras, alleviates chronic inflammation and suppresses airway remodelling in mouse model of allergic asthma by modulating pro-inflammatory cytokine response. Biomed Pharmacother. 2020; 126:110063. DOI: 10.1016/j.biopha.2020.110063. View

2.
Shin N, Lee A, Song J, Yang S, Park I, Lim J . Scrophularia buergeriana attenuates allergic inflammation by reducing NF-κB activation. Phytomedicine. 2020; 67:153159. DOI: 10.1016/j.phymed.2019.153159. View

3.
Gururani R, Patel S, Yaduvanshi N, Dwivedi J, Paliwal S, Sharma S . Tylophora indica (Burm. f.) merr: An insight into phytochemistry and pharmacology. J Ethnopharmacol. 2020; 262:113122. DOI: 10.1016/j.jep.2020.113122. View

4.
Kim H, Yoo J, Shin T, Kim S . Aqueous extract of Mosla chinensis inhibits mast cell-mediated allergic inflammation. Am J Chin Med. 2012; 40(6):1257-70. DOI: 10.1142/S0192415X12500930. View

5.
Vieira G, De Lima J, de Figueiredo R, Mascarenhas S, Bezerra-Santos C, Piuvezam M . Inhaled Cissampelos sympodialis down-regulates airway allergic reaction by reducing lung CD3+ T cells. Phytother Res. 2012; 27(6):916-25. DOI: 10.1002/ptr.4791. View